Bristol Myers Squibb
A Principal Scientist in Biotransformation within the Development DMPK team at Bristol Myers Squibb leads biotransformation activities for all pipeline assets, from candidate nomination to registration. This role involves hands-on metabolite profiling, characterizing drug metabolism and pharmacokinetic (PK) behavior, and providing strategic guidance to cross-functional teams to support IND submissions and marketing authorizations. The position focuses on both in vitro and in vivo studies for small molecules, protein therapeutics, and novel modalities.
Headquarters
Lawrence Township, New Jersey, United States
Company Size
10001+ employees
Founded
1887
Bristol Myers Squibb is a global biopharmaceutical company that discovers, develops, and delivers prescription medicines for serious diseases, with a focus on oncology, hematology, immunology, cardiovascular, neuroscience, and other therapeutic areas. The company operates in the pharmaceutical and biotechnology industry, serving patients worldwide through research, development, manufacturing, and commercialization of innovative therapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Bristol Myers Squibb.
20% below the average for this role